Most surgical glaucoma treatments work by making it easier for fluid to leave the eye. Cyclophotocoagulation (CP) takes a different approach. It works by decreasing the production of aqueous fluid.
Micro-invasive Suture Trabeculotomy (MIST) is a low risk procedure that has the potential to further reduce the IOP in eyes that have failed to respond to canaloplasty. It is neither a long nor a technically challenging surgery.
Learn the Failure Rates for Trabeculectomy and Glaucoma Drainage, Failure Rates for Canaloplasty and Phacocanaloplasty, and Failure Rates for Viscocanalostomy
What You Need To Know, Risks, When To Undergo This Treatment, and How Well Does YAG Laser Goniopuncture Work
What if Canaloplasty Doesn’t Work? Although there is evidence that canaloplasty can be an effective long-term treatment for glaucoma, studies indicate that…
Watch and learn what canaloplasty is. This was the presentation of Dr. David Ricahrdson at San Gabriel Valley Medical Center’s Healthtalk last November 2014
As with all surgical procedures, there are risks associated with Laser Trabeculoplasty. Following are some of the more commonly encountered complications associated with LT.
Laser Trabeculoplasty has a long track record of effectively lowering the IOP while presenting relatively low risk to those receiving this treatment. Selective Laser Trabeculoplasty has two key advantages over Argon Laser Trabeculoplasty: (1) it is repeatable;
The response to Laser Trabeculoplasty appears to be dependent upon the pre-treatment intraocular pressure (IOP). In other words, the higher the IOP before treatment, the better the response to Laser Trabeculoplasty.
Selective Laser Trabeculoplasty (SLT) may be repeated multiple times so long as there is an initial IOP-lowering response to the first treatment.